Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-032143
Filing Date
2024-08-14
Accepted
2024-08-14 16:00:40
Documents
114
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 946656
2 ex10-2.htm EX-10.2 27183
3 ex10-3.htm EX-10.3 32809
4 ex31-1.htm EX-31.1 21290
5 ex31-2.htm EX-31.2 20761
6 ex32-1.htm EX-32.1 6935
7 ex32-2.htm EX-32.2 6335
8 form10-q_002.jpg GRAPHIC 67927
9 form10-q_003.jpg GRAPHIC 15073
10 form10-q_004.jpg GRAPHIC 86898
11 form10-q_005.jpg GRAPHIC 15203
12 form10-q_006.jpg GRAPHIC 12417
13 form10-q_013.jpg GRAPHIC 265997
14 ex10-2_001.jpg GRAPHIC 388837
15 ex10-2_002.jpg GRAPHIC 346282
16 ex10-2_003.jpg GRAPHIC 372943
17 ex10-2_004.jpg GRAPHIC 424113
18 ex10-2_005.jpg GRAPHIC 516197
19 ex10-2_006.jpg GRAPHIC 438639
20 ex10-2_007.jpg GRAPHIC 268557
21 ex10-2_008.jpg GRAPHIC 90831
22 ex10-2_009.jpg GRAPHIC 87811
23 ex10-2_010.jpg GRAPHIC 506938
24 ex10-2_011.jpg GRAPHIC 525592
25 ex10-2_012.jpg GRAPHIC 470302
26 ex10-2_013.jpg GRAPHIC 400684
27 ex10-2_014.jpg GRAPHIC 501254
28 ex10-2_015.jpg GRAPHIC 552147
29 ex10-2_016.jpg GRAPHIC 526858
30 ex10-2_017.jpg GRAPHIC 602821
31 ex10-2_018.jpg GRAPHIC 448165
32 ex10-2_019.jpg GRAPHIC 457260
33 ex10-2_020.jpg GRAPHIC 541784
34 ex10-2_021.jpg GRAPHIC 491809
35 ex10-2_022.jpg GRAPHIC 417330
36 ex10-2_023.jpg GRAPHIC 63915
37 ex10-2_024.jpg GRAPHIC 398071
38 ex10-2_025.jpg GRAPHIC 350557
39 ex10-2_026.jpg GRAPHIC 309830
40 ex10-3_001.jpg GRAPHIC 143805
41 ex10-3_002.jpg GRAPHIC 156583
42 ex10-3_003.jpg GRAPHIC 153609
43 ex10-3_004.jpg GRAPHIC 164521
44 ex10-3_005.jpg GRAPHIC 189195
45 ex10-3_006.jpg GRAPHIC 140356
46 ex10-3_007.jpg GRAPHIC 180235
47 ex10-3_008.jpg GRAPHIC 177188
48 ex10-3_009.jpg GRAPHIC 165156
49 ex10-3_010.jpg GRAPHIC 152447
50 ex10-3_011.jpg GRAPHIC 194939
51 ex10-3_012.jpg GRAPHIC 172489
52 ex10-3_013.jpg GRAPHIC 201174
53 ex10-3_014.jpg GRAPHIC 89716
54 ex10-3_015.jpg GRAPHIC 34605
55 ex10-3_016.jpg GRAPHIC 145223
56 ex10-3_017.jpg GRAPHIC 48494
57 ex10-3_018.jpg GRAPHIC 74536
58 ex10-3_019.jpg GRAPHIC 166495
59 ex10-3_020.jpg GRAPHIC 148574
60 ex10-3_022.jpg GRAPHIC 235173
61 ex10-3_023.jpg GRAPHIC 210113
62 ex10-3_024.jpg GRAPHIC 28821
  Complete submission text file 0001493152-24-032143.txt   25454005

Data Files

Seq Description Document Type Size
63 XBRL SCHEMA FILE gtbp-20240630.xsd EX-101.SCH 41660
64 XBRL CALCULATION FILE gtbp-20240630_cal.xml EX-101.CAL 37121
65 XBRL DEFINITION FILE gtbp-20240630_def.xml EX-101.DEF 167059
66 XBRL LABEL FILE gtbp-20240630_lab.xml EX-101.LAB 329195
67 XBRL PRESENTATION FILE gtbp-20240630_pre.xml EX-101.PRE 253041
116 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 798413
Mailing Address 315 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94104
Business Address 315 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94104 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40023 | Film No.: 241207215
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)